Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7939)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2020 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen LX, Zou SJ, Li D, Zhou JY, Cheng ZT, Zhao J, Zhu YL, Kuang D, Zhu XH. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World J Gastroenterol 2020; 26(48): 7664-7678 [PMID: 33505143 DOI: 10.3748/wjg.v26.i48.7664] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i48/7664.htm |
| Number | Citing Articles |
| 1 |
Aditi A. Shirke, Jing Wang, Gopolakrishnan Ramamurthy, Arpan Mahanty, Ethan Walker, Lifang Zhang, Abhiram Panigrahi, Xinning Wang, James P. Basilion. Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model. Molecular Imaging and Biology 2024; 26(4): 714 doi: 10.1007/s11307-024-01920-2
|
| 2 |
Lixing Chen, Siyuan Cheng, Dongling Zhu, Guangfa Bao, Ziqiang Wang, Xiaoyun Deng, Xiaoguang Liu, Xiang Ma, Jun Zhao, Lei Zhu, Xiaohua Zhu. Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging. Molecular Pharmaceutics 2025; 22(1): 209 doi: 10.1021/acs.molpharmaceut.4c00838
|
| 3 |
Rishi R. Patel, Udhayvir Singh Grewal, Yiqin Xiong, Naomi Fei. Intrahepatic Cholangiocarcinoma Presenting as an Incidentaloma on F-18 PYL PSMA PET/CT. World Journal of Nuclear Medicine 2024; doi: 10.1055/s-0044-1793833
|
| 4 |
Scott M. Thompson, Garima Suman, Michael S. Torbenson, Zong‐Ming E. Chen, Danielle E. Jondal, Anurima Patra, Eric C. Ehman, James C. Andrews, Chad J. Fleming, Brian T. Welch, Anil N. Kurup, Lewis R. Roberts, Kymberly D. Watt, Mark J. Truty, Sean P. Cleary, Rory L. Smoot, Julie K. Heimbach, Nguyen H. Tran, Amit Mahipal, Jun Yin, Tyler Zemla, Chen Wang, Zachary Fogarty, Mark Jacobson, Bradley J. Kemp, Sudhakar K. Venkatesh, Geoffrey B. Johnson, David A. Woodrum, Ajit H. Goenka. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga. Hepatology Communications 2022; 6(5): 1172 doi: 10.1002/hep4.1861
|
| 5 |
Christine Kang, James Yuheng Jiang, Marco Enoch Lee, Lily Shen, Robert Mansberg. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT. Clinical Nuclear Medicine 2022; 47(3): e291 doi: 10.1097/RLU.0000000000003992
|
| 6 |
Eundong Park, Nusret Bekir Subasi, Xin Wang, Michel Kmeid, Anne Chen, Chelsea Tooke-Barry, Hwajeong Lee. CXCR2 expression is associated with prostate-specific membrane antigen expression in hepatocellular carcinoma: reappraisal of tumor microenvironment and angiogenesis. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03789-7
|
| 7 |
Aditi A. Shirke, Ethan Walker, Sriprada Chavali, Gopalakrishnan Ramamurthy, Lifang Zhang, Abhiram Panigrahi, James P. Basilion, Xinning Wang. A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer. International Journal of Molecular Sciences 2024; 25(13): 7086 doi: 10.3390/ijms25137086
|
| 8 |
Sanfeng Han, Tao Ye, Yuqin Mao, Bo Hu, Chen Wang, Tian jiao Wang. Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma. Disease Markers 2023; 2023: 1 doi: 10.1155/2023/5552798
|
| 9 |
Luca FILIPPI, Arthur J. BRAAT. Theragnostics in primary and secondary liver tumors: the need for a personalized approach. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022; 65(4) doi: 10.23736/S1824-4785.21.03407-5
|
| 10 |
Vasiliki Zoi, Maria Giannakopoulou, George A. Alexiou, Penelope Bouziotis, Savvas Thalasselis, Andreas G. Tzakos, Andreas Fotopoulos, Athanassios N. Papadopoulos, Athanassios P. Kyritsis, Chrissa Sioka. Nuclear Medicine and Cancer Theragnostics: Basic Concepts. Diagnostics 2023; 13(19): 3064 doi: 10.3390/diagnostics13193064
|
| 11 |
Veronica Chi Ken Wong, Joshua Yip, Vincenzo Fragomeli, Martin Weltman, Han Loh, Ken Le, Diep Nguyen, Chuong Bui, Robert Mansberg. Comparison between PSMA PET/CT and MRI for Characterizing Hepatocellular carcinoma: A Real-World Study. Tomography 2023; 9(1): 130 doi: 10.3390/tomography9010011
|
| 12 |
Xin‑Long Chen, Hai‑Chuan Yu, Qi‑Gang Fan, Qi Yuan, Wen‑Kai Jiang, Shao‑Zhen Rui, Wen-Ce Zhou. Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta‑analysis. Oncology Letters 2022; 24(4) doi: 10.3892/ol.2022.13486
|
| 13 |
Xiaoguang Liu, Lixing Chen, Yuying Li, Chuanchuan He, Xiaojuan Zhang, Huimin Zhou, Guangfa Bao, Xiaohua Zhu, Guangya Xiang, Xiang Ma. Synthesis of novel DOTA-/AAZTA-based bifunctional chelators: Solution thermodynamics, peptidomimetic conjugation, and radiopharmaceutical evaluation. Biomedicine & Pharmacotherapy 2023; 165: 115114 doi: 10.1016/j.biopha.2023.115114
|
| 14 |
Rena X. Li, Yansheng Hao, Mark Ettel. Expression of PSMA in Tumor-Associated Vasculature Predicts Poorer Survival in Patients With Hepatocellular Carcinoma and Is Likely Associated With PD-L1. International Journal of Surgical Pathology 2024; 32(7): 1248 doi: 10.1177/10668969241226705
|
| 15 |
Yu Sun, Haiyan Wang, Yihong Yang, Zhiwen You, Jun Zhao. Intrahepatic cholangiocarcinoma detected on 18F-PSMA-1007 PET/MR imaging in a prostate cancer patient: a case report and literature review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1408453
|
| 16 |
Shuxian An, Gang Huang, Jianjun Liu, Weijun Wei. PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers. European Journal of Nuclear Medicine and Molecular Imaging 2022; 49(12): 3973 doi: 10.1007/s00259-022-05905-7
|
| 17 |
Michel Kmeid, Young Nyun Park, Taek Chung, Georgi Lukose, Luz Sullivan, Rupinder Brar, Hwajeong Lee. PSMA Immunohistochemistry in Hepatic Neoplasms. American Journal of Surgical Pathology 2022; 46(12): 1688 doi: 10.1097/PAS.0000000000001971
|
| 18 |
Alessio Rizzo, Manuela Racca, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia. Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2022; 15(11): 1368 doi: 10.3390/ph15111368
|
| 19 |
Zhenyuan Huangfu, Jiangtao Yang, Juan Sun, Bin Xu, Lei Tao, Jiang Wu, Feng Wang, Guanglin Wang, Fenghua Meng, Zhiyuan Zhong. PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer. Journal of Controlled Release 2024; 375: 767 doi: 10.1016/j.jconrel.2024.09.040
|